Nationalität
Österreich, Deutschland
Geburtsjahr
1975
Genetik an der Universität Salzburg, B.A., 1997
Molekularbiologie an der New York University, M.S., 2000
Promoviert in Molekularbiologie an der New York University, Ph.D., 2003
2003-2005
Roche Management Development Programm “Perspectives”, Roche Singapur, Basel, Wien und Mannheim
2005-2008
Leiter Marketing und Verkauf, Roche Diagnostics Österreich, Wien
2008-2011
General Manager Roche Diagnostics
Schweden, Stockholm
2011-2013
Lifecycle Leader Sequencing Solutions, Roche Diagnostics Branford and Madison
2013-2017
General Manager Roche Diagnostics Deutschland, Mannheim, and Roche Holding Deutschland, Grenzach
Januar 2018-Juli 2019
Globaler Leiter Roche Diagnostics Centralized and Point of Care Solutions, Rotkreuz
August 2019-Dezember 2022
CEO Roche Diagnostics, Basel, Switzerland
Januar 2023-Februar 2023
Ad interim CEO Roche Pharmaceuticals
Seit März 2023
Chief Executive Officer der Roche-Gruppe
Mitglied des Innovationsbeirats von Labor Berlin (Charité und Vivantes)
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.